logo

For the Inventor, By the Inventor

Ardea, Italy

Claudio De Simone

This inventor holds 33 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Vsl Pharmaceuticals Inc., Mendes S.r.l., Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 1992-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudio De Simone. Retrieved from https://idiyas.com/inventor/claudio-de-simone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 

% Patents Active = 78.8


Average Co-Inventor Count = 1.3

ph-index = 9

Forward Citations = 240(Granted Patents)


Location History:

  • Ardea (Rome), IT (1998)
  • Ardea (Roma), IT (2000)
  • Ardea, Roma, IT (2001)
  • Ardrea, IT (2002)
  • Ardea RM, IT (2000 - 2009)
  • Ardea, IT (1997 - 2014)
  • Rome, IT (1992 - 2016)

Company Filing History:

goldMedal18 out of 19 
 
Vsl Pharmaceuticals Inc.
 patents
silverMedal4 out of 9 
 
Mendes S.r.l.
 patents
bronzeMedal4 out of 343 
 
Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.
 patents
4. 1 out of 1 
 
Mendes S.u.r.l.
 patent
5. 1 out of 1 
 
Vsl Pharma Limited
 patent
6. 1 out of 1 
 
Vsl Pharmacueticals, Inc.
 patent
7. 6 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Sphingomyelinase
Lactic Acid Bacteria
Pharmaceutical Composition
Dietary Composition
Analytical Method
Bacterial Strains
Dermatitis Treatment
Hyperoxaluria
Functional Food
Immunoglobulins
Apoptosis Induction
Vaginal Infections
33 patents (USPTO):Explore Patents
1. 9439953 - Compositions comprising alkaline sphingomyelinases for use as a dietetic preparation, food supplement or pharmaceutical product and methods for using them (2016-09-13),
2. 8697051 - Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product (2014-04-15),
3. 7959911 - Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids (2011-06-14),
4. RE41276 - STRAINS OF BACTERIA AND PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF SAME FOR PREVENTING AND TREATING DISEASES ASSOCIATED WITH OR CAUSED BY ALTERED METABOLISM OF BILE ACIDS (2010-04-26),
5. 7628981 - Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it (2009-12-08),
6. RE40457 - Enteral dietary compositions comprising a mixture of live lactic bacteria consisting of Streptococcus thermophilus, Bifidobacterium longum and Bifidobacterium infantis (2008-08-11),
7. 7323317 - Analytical method for detecting alkaline sphingomyelinase and kit for use in such method (2008-01-29),
8. RE39876 - Kit with enteral dietary composition consisting of Streptococcus thermophilus, Bifidobacterium infantis and Bifidobacterium longum (2007-10-08),
9. 7223591 - Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it (2007-05-29),
10. 7217416 - Use of gamma globulin for the topical treatment of lesions of dermatitis (2007-05-15),
11. 7211410 - Analytical method for detecting alkaline sphingomyelinase and kit for use in such method (2007-05-01),
12. 7147847 - Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria (2006-12-12),
13. RE39118 - Sphingomyelinase compositions and use thereof (2006-06-05),
14. 7052688 - Method for prevention and/or treatment of infections and inflammatory conditions using a combination of lactic acid bacteria (2006-05-30),
15. 6962697 - Use of sphingomyelinase to increase the levels of skin and mucosal ceramides, and dermatological and cosmetic compositions suitable for topical application containing same (2005-11-08),

Title: Innovations of Claudio De Simone

Introduction

Claudio De Simone is a prominent inventor based in Ardea, Italy, with an impressive portfolio of 33 patents. His groundbreaking work primarily focuses on compositions that leverage alkaline sphingomyelinases for various health applications. These innovations aim to provide dietary and therapeutic solutions for a range of health issues.

Latest Patents

Claudio's latest patents include compositions comprising alkaline sphingomyelinases that can be utilized as dietetic preparations, food supplements, or pharmaceutical products. These inventions highlight the ability of alkaline sphingomyelinase to prevent or treat several pathological conditions such as cancer, inflammatory processes of the intestine, hypercholesterolemia, and various infections. The versatility of these compositions makes them a valuable asset in the medical and dietary fields.

Career Highlights

Over his career, Claudio has made significant contributions to the field of pharmaceuticals. His work at VSL Pharmaceuticals Inc. exemplifies his commitment to innovation and development in healthcare solutions. He consistently strives to address complex health challenges through his inventions.

Collaborations

Claudio has collaborated with notable individuals in his field, including Renata Maria Anna Cavaliere ved Vesely and Renata Maria Anna Cavaliere widow Vesely. These partnerships have contributed to his success and the advancement of his innovative projects.

Conclusion

Claudio De Simone's contributions to science and healthcare through his innovative patents highlight his role as a leading inventor in the industry. His work continuously pushes the boundaries of what is possible in dietary and pharmaceutical applications, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…